Bellipanni G, Bianchi P, Pierpaoli W, Bulian D, Ilyia E
Menopause Center, Madonna delle Grazie Health Institute, Velletri, Rome, Italy.
Exp Gerontol. 2001 Feb;36(2):297-310. doi: 10.1016/s0531-5565(00)00217-5.
In aging humans, night levels of melatonin (MEL) decline progressively. Also thyroid and gonadal functions decline during aging while gonadotropins (luteotropic hormone (LH) and follicle stimulating hormone (FSH)) steadily increase. A desynchronization of pineal circadian cyclicity as expressed by the progressive decrease of the MEL night peak may be permissively linked to the onset and progression of menopause. We studied the effects of exogenous, evening administration of MEL on the level of hormones which are known to be involved in the genesis and progression of menopause. Perimenopausal and menopausal women from 42 to 62years of age with no pathology or medication were selected. MEL was measured in saliva to divide them into low, medium and high-MEL patients. Half of them took 3mg MEL and half of them Placebo at bedtime (10-12p.m.) in a fully randomized and double-blind fashion. Three and six months later blood was taken for determination of pituitary (LH, FSH), ovarian, and thyroid hormones I(T3 and T4). All women taking MEL with low basal level of MEL and/or Placebo for three and six months showed a significant increase in levels of thyroid hormones. Before initiation of the study, a negative correlation was found in all women between LH, FSH and basal MEL levels. Within six months of treatment, MEL produced a significant diminution of LH in the younger women (43 to 49year-old), while no effect was seen in the older women (50-62years old). A decrement of FSH was observed in MEL-treated women with low basal MEL levels. In addition, most MEL-treated women reported a general improvement of mood and a significant mitigation of depression. MEL decline during aging may thus signal the derangement of pineal and pituitary-controlled ovarian cyclicity and the progressive quenching of fertility in women. These findings seem to show a recovery of pituitary and thyroid functions in MEL-treated women, towards a more juvenile pattern of regulation.
在衰老的人类中,褪黑素(MEL)的夜间水平逐渐下降。此外,甲状腺和性腺功能在衰老过程中也会下降,而促性腺激素(促黄体生成素(LH)和促卵泡激素(FSH))则稳步增加。褪黑素夜间峰值的逐渐降低所表现出的松果体昼夜节律的失调,可能与更年期的开始和进展存在关联。我们研究了傍晚外源性给予褪黑素对已知参与更年期发生和进展的激素水平的影响。选取了42至62岁无疾病或未用药的围绝经期和绝经后女性。通过测量唾液中的褪黑素将她们分为低、中、高褪黑素水平的患者。其中一半在睡前(晚上10点至12点)服用3毫克褪黑素,另一半服用安慰剂,采用完全随机和双盲的方式。三个月和六个月后采集血液,用于测定垂体(LH、FSH)、卵巢和甲状腺激素(T3和T4)。所有服用低基础水平褪黑素的褪黑素组以及服用安慰剂三个月和六个月的女性,甲状腺激素水平均显著升高。在研究开始前,所有女性的LH、FSH与基础褪黑素水平之间均呈负相关。在治疗的六个月内,褪黑素使年轻女性(43至49岁)的LH显著降低,而老年女性(50至62岁)则未见效果。在基础褪黑素水平低的接受褪黑素治疗的女性中观察到FSH有所下降。此外,大多数接受褪黑素治疗的女性报告情绪普遍改善,抑郁症状明显减轻。因此,衰老过程中褪黑素的下降可能预示着松果体和垂体控制的卵巢周期性紊乱以及女性生育能力的逐渐丧失。这些发现似乎表明,接受褪黑素治疗的女性垂体和甲状腺功能有所恢复,趋向于更年轻的调节模式。